Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

Australia’s regulatory agency rejected Biogen and Eisai’s Alzheimer’s drug Leqembi, noting that the drug's efficacy doesn't ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of ...

In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...

Most Americans 50 and older don't place much trust in health advice generated by artificial intelligence, a new survey finds.

About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported ...

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

Eisai will request a reconsideration of this decision under Section 60* of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia.

India on Thursday weighed in on the ongoing diplomatic spat with Canada by holding the Trudeau administration responsible for 'precipitating' the current diplomatic fallout while acknowledging the ...

A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote ...

A murder investigation has been launched in the disappearance of Kyran Durnin, from Drogheda, Co Louth. His 24-year-old mother Dayla Durnin has since been found alive in the UK, according to the ...